Skip to main content

Table 2 EQ-5D-3 L index score by target joint status

From: The impact of severe haemophilia and the presence of target joints on health-related quality-of-life

  Total (n = 515) No target joints (n = 157) ≥1 target joints (n = 358)
Total 0.77 ± 0.27 0.87 ± 0.01 0.73 ± 0.29
Age categories
 18–30 0.86 ± 0.01 0.94 ± 0.01 0.82 ± 0.21
 31–40 0.78 ± 0.23 0.84 ± 0.16 0.74 ± 0.25
 41–50 0.72 ± 0.28 0.86 ± 0.12 0.69 ± 0.30
 51–60 0.67 ± 0.34 0.83 ± 0.19 0.63 ± 0.36
 61 + 0.61 ± 0.36 0.73 ± 0.31 0.54 ± 0.36
Subtype
 Haemophilia A 0.78 ± 0.26 0.87 ± 0.18 0.74 ± 0.28
 Haemophilia B 0.76 ± 0.29 0.86 ± 0.18 0.70 ± 0.32
Country
 France 0.75 ± 0.28 0.87 ± 0.18 0.69 ± 0.30
 Germany 0.90 ± 0.12 0.93 ± 0.09 0.88 ± 0.13
 Italy 0.85 ± 0.12 0.86 ± 0.14 0.84 ± 0.11
 Spain 0.66 ± 0.34 0.71 ± 0.36 0.65 ± 0.33
 UK 0.59 ± 0.36 0.78 ± 0.17 0.56 ± 0.38
Treatment strategy
 On-demand 0.80 ± 0.26 0.87 ± 0.21 0.77 ± 0.27
 Prophylaxis 0.75 ± 0.01 0.87 ± 0.01 0.71 ± 0.29
Physician reported comorbidities
 Depression 0.60 ± 0.36 0.79 ± 0.33 0.55 ± 0.35
 Anxiety 0.80 ± 0.26 0.87 ± 0.21 0.77 ± 0.27
Number of target joints (patient n, %)
 One 0.76 ± 0.28
 Two 0.76 ± 0.26
 Three or more 0.62 ± 0.31
Location of target joints (patient n, %)
 Exclusively upper body 0.77 ± 0.27
 Exclusively lower body 0.73 ± 0.28
 Upper and lower body 0.68 ± 0.31
  1. Note: Values are means ± SD